# NHS National Framework Agreement for Adalimumab Injection

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Amgen Ltd\.
- Award value: £445,000,000
- Tender value: £125,000,000
- Award date: 6 March 2020
- Published: 21 May 2020
- Contract start: 1 April 2020
- Contract end: 31 March 2022
- Stage: awarded
- Procurement category: goods
- Notice ID: 0ed6ad81-db81-4d2a-a3c2-d8917c178742-360114
- OCID: ocds-b5fd17-f96f894b-efb7-43e5-a819-406e064cdcb2

## Description

NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575 Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab](/contracts/ocds-b5fd17-bd18e8bf-f1dd-455f-8b23-688c3cad9f30): NHS England
- [NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024](/contracts/ocds-b5fd17-f8f31612-30fe-46cd-8155-9f4881ec58c8): NHS England
- [NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023](/contracts/ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/0ed6ad81-db81-4d2a-a3c2-d8917c178742-360114)